Katherine Whittinghill Seay

Katherine Whittinghill Seay has a diverse work experience spanning various positions in the pharmaceutical and healthcare industry. Katherine'smost recent role is as a Member at Chief, a private network aimed at empowering women executives and promoting gender diversity in leadership positions. Prior to that, they worked as the Executive Vice President of Sales and Operations at Clinical Trial Media.

From 2016 to 2022, Seay held multiple roles at Syneos Health Communications, including EVP, Managing Director, SVP, Managed Markets Content Expert and Strategist, and VP, Managed Markets Content Expert and Strategist.

Before that, they worked at Salix Pharmaceuticals, first as the Sr. Brand Manager for RUCONEST, where they managed all aspects of marketing for a biologic product in the orphan disease state of Hereditary Angioedema (HAE). Katherine then served as the Sr. Manager of Managed Markets Marketing for the GI and Orphan Drug Portfolio, and later as the Regional Sales Manager for the GI Portfolio.

Seay's career started at AstraZeneca Pharmaceuticals in 2001, where they held various positions, including Executive District Sales Manager, Sales Trainer, CNS Specialty Care Representative, and Cardiovascular Pharmaceutical Sales Specialist. Katherine achieved notable success as an Executive District Sales Manager, leading a team of 11 salespeople and consistently ranking in the top 10% nationally.

Seay began their professional journey as a Pharmaceutical Healthcare Representative at Pfizer Pharmaceuticals in 1999.

Katherine Whittinghill Seay achieved an MBA in Business from Colorado State University between 2006 and 2008. Prior to that, they obtained a B.S. in Biochemistry from Virginia Tech from 1994 to 1998. Though no specific dates are provided, it is mentioned that they have some affiliation with Vanderbilt University, but their degree and field of study remain unknown.